monomethylpropion has been researched along with Autosomal Dominant Juvenile Parkinson Disease in 11 studies
monomethylpropion: metabolite of dimethylpropion; structure given in first source
2-methylamino-1-phenylpropan-1-one : An aromatic ketone that is propiophenone in which the hydrogen alpha- to the keto group has been replaced by a methylamino group.
methcathinone : A racemate comprising equal amounts of (R)- and (S)-methcathinone.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The patients had a parkinsonian syndrome with symmetrical bradykinesia, dystonias, and postural, gait and speech impairment, with moderate restrictions in activities of daily living." | 1.56 | Cognitive profile of patients with manganese-methcathinone encephalopathy. ( Ennok, M; Haldre, S; Sikk, K; Taba, P, 2020) |
| "A number of cases of severe parkinsonism-dystonia have been recognized and reported following the illicit use of ephedrone prepared from pseudoephedrine and potassium permanganate." | 1.56 | Neuropathological Findings in Ephedrone Encephalopathy. ( Dziewulska, D; Fedoryshyn, L; Holton, JL; Kuzyk, P; Lees, AJ; Matviyenko, Y; Sanotsky, Y; Selikhova, M; Semeryak, O, 2020) |
| "A permanent Parkinsonian syndrome occurs in intravenous abusers of the designer psychostimulant methcathinone (ephedrone)." | 1.43 | Grey matter abnormalities in methcathinone abusers with a Parkinsonian syndrome. ( Donaghy, M; Ilves, P; Johansen-Berg, H; Juurmaa, J; Menke, RA; Müürsepp, A; Nigul, M; Stagg, CJ; Stepens, A; Taba, P; Tomberg, T; Vila, P, 2016) |
| "In ephedrone-induced parkinsonism a prominent mixed hyperkinetic-hypokinetic dysarthria occurs that appears related to marked dystonia and bradykinesia and probably reflects manganese induced toxic and neurodegenerative damage to the globus pallidus internus and substantia nigra." | 1.40 | A distinct variant of mixed dysarthria reflects parkinsonism and dystonia due to ephedrone abuse. ( Bonnet, C; Brožová, H; Janelidze, M; Khatiashvili, I; Megrelishvili, M; Okujava, M; Rusz, J; Růžička, E; Sekhniashvili, M; Tolosa, E, 2014) |
| "Patients with ephedrone parkinsonism (EP) show a complex, rapidly progressive, irreversible, and levodopa non-responsive parkinsonian and dystonic syndrome due to manganese intoxication." | 1.40 | Eye movements in ephedrone-induced parkinsonism. ( Bergquist, J; Bonnet, C; Botchorishvili, N; Brožová, H; Fiala, O; Gaymard, B; Hanuška, J; Janelidze, M; Jech, R; Kapianidze, M; Khatiashvili, I; Matoušková, O; Megrelishvili, M; Mikeladze, N; Nikolai, T; Okujava, M; Rivaud-Péchoux, S; Roth, J; Rusz, J; Růžička, E; Serranová, T; Sieger, T, 2014) |
| "A new form of presumed manganese poisoning has been reported in drug-addicted persons from Russia, Ukraine, and Estonia who have intravenously injected self-prepared methcathinone hydrochloride (Ephedrone)." | 1.34 | Manganese-induced Parkinsonism associated with methcathinone (Ephedrone) abuse. ( de Bie, RM; Gladstone, RM; Ko, JH; Lang, AE; Strafella, AP, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 6 (54.55) | 24.3611 |
| 2020's | 2 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Ennok, M | 1 |
| Sikk, K | 3 |
| Haldre, S | 3 |
| Taba, P | 4 |
| Sanotsky, Y | 2 |
| Selikhova, M | 2 |
| Fedoryshyn, L | 2 |
| Kuzyk, P | 1 |
| Matviyenko, Y | 2 |
| Semeryak, O | 1 |
| Dziewulska, D | 1 |
| Holton, JL | 1 |
| Lees, AJ | 1 |
| Rusz, J | 2 |
| Megrelishvili, M | 2 |
| Bonnet, C | 2 |
| Okujava, M | 2 |
| Brožová, H | 2 |
| Khatiashvili, I | 2 |
| Sekhniashvili, M | 1 |
| Janelidze, M | 2 |
| Tolosa, E | 1 |
| Růžička, E | 2 |
| Koksal, A | 1 |
| Keskinkılıc, C | 1 |
| Sozmen, MV | 1 |
| Dirican, AC | 1 |
| Aysal, F | 1 |
| Altunkaynak, Y | 1 |
| Baybas, S | 1 |
| Golasik, M | 1 |
| Wodowski, G | 1 |
| Gomółka, E | 1 |
| Herman, M | 1 |
| Piekoszewski, W | 1 |
| Sieger, T | 1 |
| Matoušková, O | 1 |
| Nikolai, T | 1 |
| Hanuška, J | 1 |
| Kapianidze, M | 1 |
| Mikeladze, N | 1 |
| Botchorishvili, N | 1 |
| Serranová, T | 1 |
| Fiala, O | 1 |
| Roth, J | 1 |
| Bergquist, J | 3 |
| Jech, R | 1 |
| Rivaud-Péchoux, S | 1 |
| Gaymard, B | 1 |
| Juurmaa, J | 1 |
| Menke, RA | 1 |
| Vila, P | 1 |
| Müürsepp, A | 1 |
| Tomberg, T | 1 |
| Ilves, P | 1 |
| Nigul, M | 1 |
| Johansen-Berg, H | 1 |
| Donaghy, M | 1 |
| Stagg, CJ | 1 |
| Stepens, A | 1 |
| Komnatska, I | 1 |
| Kyrylchuk, M | 1 |
| Krolicki, L | 1 |
| Friedman, A | 1 |
| Taylor, A | 1 |
| Jäger, HR | 1 |
| Lees, A | 1 |
| Nyholm, D | 2 |
| Askmark, H | 1 |
| Danfors, T | 1 |
| Sörensen, J | 1 |
| Thurfjell, L | 1 |
| Raininko, R | 1 |
| Eriksson, R | 1 |
| Flink, R | 1 |
| Färnstrand, C | 1 |
| Aquilonius, SM | 2 |
| Zjablov, G | 1 |
| Asser, T | 1 |
| de Bie, RM | 1 |
| Gladstone, RM | 1 |
| Strafella, AP | 1 |
| Ko, JH | 1 |
| Lang, AE | 1 |
11 other studies available for monomethylpropion and Autosomal Dominant Juvenile Parkinson Disease
| Article | Year |
|---|---|
Cognitive profile of patients with manganese-methcathinone encephalopathy.
Topics: Adolescent; Adult; Brain Diseases; Cognition; Cognitive Dysfunction; Female; Humans; Male; Manganese | 2020 |
Neuropathological Findings in Ephedrone Encephalopathy.
Topics: Adult; Brain Diseases; Female; Humans; Manganese Poisoning; Parkinsonian Disorders; Propiophenones | 2020 |
A distinct variant of mixed dysarthria reflects parkinsonism and dystonia due to ephedrone abuse.
Topics: Acoustics; Adult; Analysis of Variance; Antiparkinson Agents; Dysarthria; Dystonia; Humans; Magnetic | 2014 |
Evaluation of cognitive characteristics of patients developing manifestations of parkinsonism secondary to long-term ephedrone use.
Topics: Adult; Cognition Disorders; Humans; Male; Manganese Poisoning; Neuropsychological Tests; Parkinsonia | 2014 |
Urine as a material for evaluation of exposure to manganese in methcathinone users.
Topics: Humans; Manganese; Parkinsonian Disorders; Propiophenones; Spectrophotometry, Atomic | 2014 |
Eye movements in ephedrone-induced parkinsonism.
Topics: Adult; Basal Ganglia; Brain; Eye Movements; Female; Humans; Male; Manganese; Middle Aged; Parkinsoni | 2014 |
Grey matter abnormalities in methcathinone abusers with a Parkinsonian syndrome.
Topics: Adult; Atrophy; Brain; Case-Control Studies; Female; Gray Matter; Humans; Magnetic Resonance Imaging | 2016 |
Parkinsonism and dystonia caused by the illicit use of ephedrone--a longitudinal study.
Topics: Adolescent; Adult; Brain; Dystonic Disorders; Humans; Illicit Drugs; Longitudinal Studies; Magnetic | 2008 |
Clinical, neuroimaging and neurophysiological features in addicts with manganese-ephedrone exposure.
Topics: Adult; Basal Ganglia Diseases; Corpus Striatum; Female; Humans; Magnetic Resonance Imaging; Male; Ma | 2010 |
Irreversible motor impairment in young addicts--ephedrone, manganism or both?
Topics: Adult; Brain; Central Nervous System Stimulants; Disability Evaluation; Disease Progression; Dyskine | 2007 |
Manganese-induced Parkinsonism associated with methcathinone (Ephedrone) abuse.
Topics: Adult; Brain Diseases; Humans; Magnetic Resonance Imaging; Male; Manganese Poisoning; Parkinsonian D | 2007 |